E-Health after breast biopsy: a simple call may ease pain and worry
NCT ID NCT04456920
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether e-health tools—like a phone call from a specialist or a self-report app—can help manage pain and anxiety after a breast biopsy. About 193 women took part. The goal was to see if these check-ins lead to less pain and better well-being compared to standard care alone.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- phone consultation and e-PRO self-completed via connected objects
- What this could lead to
- If successful, this could show that simple e-health follow-ups reduce pain and anxiety after breast biopsy, improving patient comfort.
- What could go wrong
- This is a small, completed study without a treatment drug. The benefits may be modest and not apply to all patients or settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
193 people
The number who actually took part.
- Started
-
Feb 2021
- Finished
-
Apr 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patient with diagnostic breast biopsy at ICM * Age \> 18 years * Informed patient and signed informed consent received * Affiliation to a social security system Exclusion Criteria: * Patient without phone number * Patient with previous biopsy in 6 months prior to study * Pregnant and breastfeeding woman * Patient whose regular follow-up is initially impossible for psychological, family, social or geographical reasons * Patient under legal protection (guardianship, curatorship or safeguarding of justice)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Biopsy wound are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Icm Val D'Aurelle
Montpellier, Hérault, 34298, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a faster radiation course match the standard one after breast reconstruction?
- Can High-Risk breast cancer patients skip an extra radiation boost?
- Radioactive probe lights up CD73 on breast tumors in PET scans
- Can time with horses help cancer patients feel better?
- Can an oral drug replace injections for advanced breast cancer?
- Can a common steroid shield breast cancer patients from a dangerous drug side effect?